T1 glottic laryngeal cancer: the role of routine follow-up visits in detecting local recurrence
: Pakkanen Pihla, Ilmarinen Taru, Halme Elina, Irjala Heikki, Koivunen Petri, Pukkila Matti, Ventelä Sami, Hagström Jaana, Aaltonen Leena-Maija
Publisher: Springer Science and Business Media Deutschland GmbH
: 2021
: European Archives of Oto-Rhino-Laryngology
: European Archives of Oto-Rhino-Laryngology
: 1434-4726
DOI: https://doi.org/10.1007/s00405-021-06983-3
: https://link.springer.com/article/10.1007%2Fs00405-021-06983-3
: https://research.utu.fi/converis/portal/detail/Publication/66618881
Purpose We assessed the treatment outcome and the benefts of routine follow-up visits in T1 glottic laryngeal squamous
cell carcinoma (LSCC).
Methods: Medical records of patients diagnosed with stage T1 glottic LSCC (N=303) in fve Finnish university hospitals between 2003 and 2015 were reviewed. Moreover, data from the Finnish Cancer Registry and the Population Register Center were collected.
Results: Of all 38 recurrences, 26 (68%) were detected during a routine follow-up visit, and over half (21 of 38, 55%) presented without new symptoms. Primary treatment method (surgery vs. radiotherapy) was not connected with 5-year diseasespecifc survival (DSS) or laryngeal preservation rate.
Conclusion: The majority of recurrences were detected on a routine follow-up visit, and local recurrences often presented without new symptoms. Routine post-treatment follow-up of T1 glottic LSCC seems benefcial.
Trial registration Trial registration number and date of registration HUS/356/2017 11.12.2017.
